DELRAY BEACH, Fla., Feb. 26, 2026 /PRNewswire/ -- According to MarketsandMarkets, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and USD 30.39 billion by 2032, exhibiting a CAGR of 6.2% during the forecast period.
Browse 165 market data Tables and 75 Figures spread through 255 Pages and in-depth TOC on " Pharmaceutical Manufacturing Equipment Market - Global Forecast to 2032"
Pharmaceutical Manufacturing Equipment Market Size & Forecast:
- Market Size Available for Years: 2021-2032
- 2026 Market Size: USD 21.24 billion
- 2032 Projected Market Size: USD 30.39 billion
- CAGR (2026-2032): 6.2%
Pharmaceutical Manufacturing Equipment Market Trends & Insights:
- Demand for pharmaceutical manufacturing equipment is driven by the rising production of generic and biologic drugs, increasing investments in pharmaceutical R&D, and the expansion of manufacturing facilities worldwide. Growing emphasis on regulatory compliance, quality assurance, and process automation further support market growth.
- By equipment type, the packaging machines segment is expected to hold a 52.4% share of the market in 2026.
- By end-product type, liquid segment is expected to grow at the highest CAGR during the forecast period.
- By technology, the automatic segment is expected to record a CAGR of 6.6% from 2026 to 2032.
- By region, Asia Pacific is expected to dominate the pharmaceutical manufacturing equipment market, growing at a CAGR of 6.9% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=268102519
The market is expanding due to the rising production of branded generic biologic drugs. The growing prevalence of chronic disease is increasing drug output requirements. Additionally, expanding healthcare access supports higher production volumes. Regulatory compliance remains a key requirement across facilities. Demand for sterile injectables and vaccines is rising, while continuous manufacturing technologies are gaining adoption. Manufacturers integrate automation to improve efficiency. Regulatory standards encouraging equipment modernization and research investment increase the use of high-potency medicines, driving the market.
"Packaging machines segment is expected to register a significant growth rate between 2026 and 2032"
The packaging machines segment is likely to dominate the pharmaceutical manufacturing equipment market during the forecast period, due to its role in ensuring product safety and regulatory compliance. Packaging represents the final stage of production and directly affects product integrity and labelling accuracy. Shelf life and patient safety depend on secure packaging systems. Strict serialization and tamper-evident requirements increase investment in advanced solutions. Track and trace systems drive the integration of automated packaging lines. Packaging demand is strengthened by the requirement for manufacturers' compliance with global anti-counterfeiting regulations, as well as the growing production of tablets and capsules. The segmental growth is further driven by the need for high-speed precision systems and the expansion of generic drug manufacturing. Furthermore, the need for compliant packaging systems due to rising exports and contract manufacturing growth drives the segment.
"Solid end-product type captured the largest share of the global pharmaceutical manufacturing equipment market in 2025"
The solid end-product type is expected to dominate the global pharmaceutical manufacturing equipment market during the forecast period due to the high production volume of tablets, capsules, and powders. Solid dosage forms offer longer shelf life and easier storage. Pharmaceutical companies invest in granulation systems and tablet compression presses. Coating machines and capsule filling systems maintain batch consistency and regulatory compliance. The rising prevalence of chronic diseases increases the demand for oral medicines, while the growth in generic drug production strengthens solid formulation output. Contract manufacturing expansion also supports equipment demand. Increasing consumption of oral medications across developed and emerging markets is supporting the growth of the solid dosage segment. Drug manufacturers focus on high-speed tableting and capsule production lines to improve output and reduce operational costs.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=268102519
"Germany is expected to grow at the highest CAGR in the European pharmaceutical manufacturing equipment market during the forecast period"
Germany is expected to grow at the fastest CAGR in the European pharmaceutical manufacturing equipment industry during the forecast period due to its strong pharmaceutical production ecosystem. Continuous investment in advanced manufacturing technologies is driving equipment upgrades. Leadership in automation and precision engineering supports high-performance systems. Adoption of Industry 4.0 enables connected production environments. Expansion of biologics and vaccine manufacturing increases the demand for aseptic processing. Fill finish and containment systems are gaining importance. Capacity expansion by pharmaceutical companies supports equipment investment. CDMOs are upgrading facilities to meet global standards. Stringent regulatory requirements drive the modernization of production lines. These factors support sustained demand for compliant and technologically advanced manufacturing equipment in the country.
Key Players
Leading players in the global pharmaceutical manufacturing equipment companies include GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), Thermo Fisher Scientific Inc (US), Körber AG (Germany), Coperion GmbH (Germany), Romaco Group (Germany), Marchesini Group S.p.A (Italy), and Bausch+Ströbel SE + Co. KG (Germany).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=268102519
Browse Adjacent Market: Semiconductor and Electronics Market Research Reports &Consulting
See More Latest Semiconductor Reports:
Home Automation System Market by Lighting Controls, Smart Speakers, Entertainment Controls, HVAC Controls, Security & Access Controls, Wired, Wireless, Behavioral, Proactive, Multi-family Residence, Single - family Residence - Global Forecast To 2032
Computational Storage Market by Offering (Hardware (Processor and SSD), Software), Type (Fixed Computational Storage and Programmable Computational Storage), End-use Industry, and Region - Global Forecast to 2032
About MarketsandMarkets
MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/pharmaceutical-manufacturing-equipment-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/pharmaceutical-manufacturing-equipment.asp
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/pharmaceutical-manufacturing-equipment-market-worth-30-39-billion-by-2032---exclusive-report-by-marketsandmarkets-302698018.html
